2025 Buick Enclave Preferred
2.5 L • I4 • FWD • AT
5GAERARS5SJ101846
Sales history: 1
Highlights
Condition
Run and drive
Seller
Insurance • USAA
Key included
Yes
Docs
Good
History
1 record
Drive
2.5 L • I4 • FWD • AT
Odometer
636 mi ≈ 1,024 km
Primary damage
Front end
Secondary damage
Top roof
Docs
Salvage >75% Damage
Extra
Auction
VIN
5GAERARS5SJ101846
Lot number
80713394
Copart
Sale status
Sold
Seller type
Insurance
Seller
USAA
Location
Baltimore, MD
Description
Fuel type
Gasoline
Body color
White
Body type
SUV
Generation
Gen III
Trim
Preferred
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
2025 Buick Enclave Preferred • 2.5 L • I4 • FWD • Automatic • Copart Lot: 80713394 • VIN: 5GAERARS5SJ101846
Find out more about this 2025 Buick Enclave Preferred, available at the Copart salvage car auction as lot 80713394 in Baltimore, MD. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 636 mi. This White Buick Enclave SUV is equipped with Gasoline 2.5 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 5GAERARS5SJ101846 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
